These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27710863)

  • 21.
    Pluta R; Kocki J; Bogucki J; Bogucka-Kocka A; Czuczwar SJ
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease.
    Das HK
    Front Biosci; 2008 Jan; 13():822-32. PubMed ID: 17981591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Markers of Alzheimer's Disease.
    Nikolac Perkovic M; Pivac N
    Adv Exp Med Biol; 2019; 1192():27-52. PubMed ID: 31705489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease?
    Pluta R
    Neurol Res; 2006 Sep; 28(6):665-71. PubMed ID: 16945220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain.
    Pluta R
    Curr Neurovasc Res; 2007 May; 4(2):121-9. PubMed ID: 17504210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.
    Ułamek-Kozioł M; Kocki J; Bogucka-Kocka A; Petniak A; Gil-Kulik P; Januszewski S; Bogucki J; Jabłoński M; Furmaga-Jabłońska W; Brzozowska J; Czuczwar SJ; Pluta R
    J Alzheimers Dis; 2016 Jul; 54(1):113-21. PubMed ID: 27472881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.
    Pluta R; Bogucka-Kocka A; Ułamek-Kozioł M; Bogucki J; Januszewski S; Kocki J; Czuczwar SJ
    Pharmacol Rep; 2018 Oct; 70(5):881-884. PubMed ID: 30096486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recent advances in the studies on Alzheimer's diseases].
    Tsuji S
    Rinsho Shinkeigaku; 1998 Dec; 38(12):983-7. PubMed ID: 10349334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
    Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
    Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Presenilins as a marker of Alzheimer's disease].
    Scheper W; van Gool WA
    Ned Tijdschr Geneeskd; 1998 May; 142(22):1247-52. PubMed ID: 9749296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer's Disease Type.
    Pluta R; Czuczwar SJ; Januszewski S; Jabłoński M
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.
    Pluta R; Miziak B; Czuczwar SJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins.
    Selkoe DJ
    Neurol Clin; 2000 Nov; 18(4):903-22. PubMed ID: 11072267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer lesions after ischemia-reperfusion brain injury.
    Pluta R
    Folia Neuropathol; 2004; 42(3):181-6. PubMed ID: 15535038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.